Chronic obstructive pulmonary
disease (COPD) is a descriptive medical
term for a number of similar overlapping diseases that include chronic
bronchitis, emphysema and some chronic asthma that has become resistant
to treatment. These conditions have in common a persistent and slowly
progressive pattern of symptoms such as shortness of breath, cough
and wheeze. In particular, on formal measurement they all share
reduced flow of air through the bronchial tubes, due to narrowing
or damage.
Chronic bronchitis
means having a cough with sputum for at least three months a year
for two consecutive years. In its mildest form this could simply
be a smoker’s cough in the morning with small amounts of
sputum. Severe chronic bronchitis, on the other hand, involves
a much greater degree of cough and sputum linked with shortness
of breath, wheeze and frequent episodes of acute bronchitis, especially
during the winter months. Chronic bronchitis relates to producing
excess amounts of phlegm with narrowing of breathing tubes.
Emphysema can be
more difficult to diagnose clinically until more advanced. The
symptoms are shortness of breath with wheeze and chest tightness.
They are caused by permanent damage to the small breathing tubes
and air sacs where oxygen and carbon dioxide are exchanged with
the blood.
Chronic bronchitis and emphysema often occur
in the same patient. Both conditions tend to start after the age
of 50 and are more common in men than women.
What causes COPD?
By far the most common cause is cigarette smoking.
Generally, the greater the tobacco exposure the greater the risk
of developing CPD. About 15% of smokers will develop symptoms
of COPD but what makes this group susceptible to cigarette smoke
compared with other smokers is not at present understood. Other
risk factors for COPD are working in dusty environments or, possibly,
living in industrialised large cities. Rarely, emphysema is a
result of a inherited deficiency of protective protein called
alpha-1—antitrypsin.
How common is it and how does it progress?
After the age of 50, COPD causes an increasing number
of visits to GPs and hospital - in one survey, 12% of all medical
hospital admissions were due to COPD.
The progression of COPD, while smoking continues,
is one of steady deterioration towards increasing disability and
death. In 1992 there were 26033 deaths in England and Wales from
COPD.
If patients stop smoking, symptoms and lung
damage remain largely unchanged. Unfortunately, damage to the
lung does not repair itself. But the progression to disability
does not occur, and any deterioration thereafter is slight and
no different from a non-smoker. Sometimes, if the main symptom
is cough and sputum, this may completely resolve.